NCT03544996 is a clinical trial of TD Insulin in Hypoinsulinemia, sponsored by Transdermal Delivery Solutions Corp.

Who is sponsoring NCT03544996?

NCT03544996 is sponsored by Transdermal Delivery Solutions Corp.

What drugs are being tested in NCT03544996?

Interventions in NCT03544996: TD Insulin.

What condition does NCT03544996 study?

NCT03544996 studies Hypoinsulinemia.

Is NCT03544996 still recruiting?

NCT03544996 is currently completed. Last updated 6 June 2018.

Last reviewed 2018-06-06 · How we verify

NCT03544996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transdermally Delivered Human Insulin Product

Completed Last updated 6 June 2018

What this trial tests

trial testing TD Insulin in Hypoinsulinemia in 1 participant. Completed in 4 February 2018.

Timeline

9 September 2017

Primary endpoint
4 February 2018

4 February 2018

Quick facts

Lead sponsor	Transdermal Delivery Solutions Corp
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1
Start date	9 September 2017
Primary completion	4 February 2018
Estimated completion	4 February 2018
Sites	1 location across United States

Drugs / interventions tested

TD Insulin

Conditions studied

Hypoinsulinemia — all drugs for Hypoinsulinemia →

Sponsor

Transdermal Delivery Solutions Corp — full company profile →

Who can join

Adults 60 to 61, male only, with Hypoinsulinemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

An Early Feasibility Study of a device formulation to deliver human insulin across intact skin

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Advances in transdermal insulin delivery.
Zhang Y, Yu J, Kahkoska AR, Wang J, et al · · 2019 · cited 201× · PMID 30528729 · DOI 10.1016/j.addr.2018.12.006
Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies.
Allamreddy S, Arora M, Ganugula R, Friend R, et al · · 2025 · cited 2× · PMID 39952688 · DOI 10.1124/pharmrev.124.001074

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03544996 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Transdermal Delivery Solutions Corp
Last refreshed: 6 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03544996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing